CSI Market
Sign In | Register

Microbot Medical Inc (MBOT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MBOT Annual Cash Flow →
The quarterly cash flow data below helps track how Microbot Medical Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-9.30
Depreciation & amortization0.03
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories2.32
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.66
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Goodwill And Intangible Asset Impairment-
Gain From Settlement Agreement Net-
Change In Fair Value Of Warrant Liability-
Increase Decrease In Accrued Wind Down Expenses-
Increase Decrease In Deferred Rent-
Amortization Of Debt Discount And Debt Issuance Costs-
Conversion Of C I R M Loan Into Grant-
Interest Expense Debt-
Loss On Legal Settlement-
Increase Decrease In Legal Settlement And Legal Expenses Received In Cash-
Marketable Securities Unrealized Gain Loss-0.22
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable1.40
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-0.07
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-5.08
Discontinued operations0.00
Net Cash flow from Operating Activities-10.04
Investing Activities
Capital Expenditures-0.25
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities11.75
Payments to Acquire Marketable Securities-1.07
Real Estate Investments0.00
Proceeds From Sale And Maturity Of Marketable Debt Securities-
Proceeds From Sale And Maturity Of Marketable Equity Securities-
Payments To Acquire Intangibles And Other Assets-
Proceeds From Sale Maturity And Collections Of Investments Excluding Marketable Securities-
Payments To Increase Longterm Deposit-0.15
Payments to Acquire Restricted Investments-0.81
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.15
Discontinued operations0.00
Net Cash Flow from Investing Activities9.47
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.02
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Debt Instrument Periodic Payment-
Repayment Of Debt Obligations-
Acquisition Of Subsidiary In Connection With Reverse Recapitalization-
Transaction Costs Incurred In Reverse Recapitalization-
Inflows In Connection With Current Assets And Liabilities Acquired In Reverse Recapitalization Net-
Exercise Of Warrants Issued Upon Conversion Of Notes-
Outflow In Connection With Current Assets And Liabilities Acquired In Reverse Recapitalization Net-
Cashless Exercise Of Warrants Issued Upon Conversion Of Notes-
Repayment Of Shareholders Investment-
Issuance Expenses Not Paid-
Stock Issued-
Accrued Bonus Settled Through Grant Of Stockoption Awards-
Deferred Issuance Expenses-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.02
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.29
Total Cash Flow-0.56
4 historic quarters locked

Sign in to unlock the full Microbot Medical Inc cash flow history.

Sign In Create Free Account

About Microbot Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 11, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-037009

Figures are derived from filed reports and may be restated. Historical data is subject to revision.